Ingredients

Urolithin A vs Ellagic Acid: Metabolite vs Precursor

Written by ReCellence™ Editorial Team, Health Content SpecialistsReviewed by Medical Review Board, MD, PhDLast reviewed: March 7, 2026

Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.

What Each Is

Urolithin A

Dietary Supplement

Urolithin A is the downstream metabolite with demonstrated PINK1/Parkin mitophagy activity. Direct supplementation achieves measurable plasma levels within 2–4 hours. FDA GRAS status. 8–10 published human trials.

Ellagic Acid

Dietary Supplement

Ellagic acid is a polyphenol found in pomegranates, berries, and walnuts. Requires gut bacterial transformation (6+ steps) to become UA. Oral bioavailability extremely low (<1% absorbed intact). Has independent antioxidant and anti-inflammatory research.

Evidence Type Comparison

Understanding the difference in evidence quality between these options.

AspectUrolithin AEllagic Acid
FDA StatusFDA GRAS status (2018)Not FDA-approved (dietary polyphenol)
Bioactive FormDownstream metabolite (mitophagy activator)Upstream precursor (requires 6+ conversion steps)
Oral BioavailabilityMeasurable plasma levels (2–4 hours)<1% absorbed intact (extremely low)
Primary MechanismPINK1/Parkin mitophagyAntioxidant, free radical scavenger (in vitro)
Conversion DependencyNone (direct)Requires Gordonibacter and related gut bacteria
Cancer ClaimsNone (no FDA-approved claims)FDA warning letters for unapproved cancer claims

Mechanism Hypotheses (Conceptual)

Note: Mechanism hypotheses describe how compounds are thought to work based on laboratory research. This does not confirm clinical benefit or efficacy in humans.

Urolithin A

UA directly activates the PINK1/Parkin mitophagy pathway, selectively clearing damaged mitochondria. Achieves measurable plasma levels when supplemented directly.

Ellagic Acid

Ellagic acid is released when gut enzymes hydrolyze ellagitannins. Gut bacteria convert it through multiple intermediate steps to UA. Ellagic acid itself scavenges free radicals and has been investigated for DNA protection in preclinical models. However, oral bioavailability is very low (<1% absorbed intact).

Critical difference: Ellagic acid is a precursor with <1% oral bioavailability and requires gut bacterial conversion (6+ steps) to become the bioactive UA. UA is the downstream metabolite that directly activates mitophagy and achieves measurable plasma levels. Ellagic acid has independent antioxidant properties but limited systemic effects due to poor absorption.

Safety & Tolerability Patterns

Urolithin A

Favorable safety profile. FDA GRAS status. Tested at up to 2000 mg/day for 28 days and 1000 mg/day for 4 months. Mild GI symptoms most common.

Ellagic Acid

Favorable safety profile. Naturally occurring dietary polyphenol with long history of food consumption. Extremely low bioavailability limits both therapeutic potential and toxicity risk. May inhibit certain CYP enzymes in vitro, but clinical significance at dietary doses is unclear.

Key difference: Both have favorable safety profiles. Ellagic acid's extremely low bioavailability limits both its effects and risks. UA achieves measurable plasma levels, making it more pharmacologically active.

Drug Interaction Considerations

Ellagic acid may inhibit certain CYP enzymes in vitro, but clinical significance at dietary doses is unclear. UA has no reported specific drug interactions but comprehensive studies are lacking. Always discuss any supplements with your pharmacist, especially if you take prescription medications.

Always discuss any supplements with your pharmacist, especially if you take prescription medications.

Decision Factors to Discuss Clinically

These factors should be discussed with your healthcare provider—not decided based on online information alone:

  • •Current medications and potential interactions
  • •Other health conditions (comorbidities)
  • •Symptom severity and impact on quality of life
  • •Your goals and preferences for treatment approach
  • •How you'll objectively track symptom changes (e.g., IPSS scores)

Questions to Bring to Your Appointment

Discussing supplements with your healthcare provider

1

Between these supplements, which has the most evidence for prostate symptoms?

Comparing DIM to saw palmetto, beta-sitosterol, etc.

2

Could combining supplements increase side effect risk?

Understanding multi-ingredient formulas

3

How do I choose a quality supplement product?

Third-party testing, standardization, reputable brands

4

What's a reasonable trial period before deciding if a supplement works?

Timeline for evaluation

5

At what point should I consider prescription options instead?

Knowing when supplements aren't enough

Tip: Write down these questions before your appointment. Bring a list of all current medications and supplements you take, including dosages. Consider asking about objective symptom tracking to measure changes over time.

Quick Answers

Q1.

Is ellagic acid the same as Urolithin A?

No. Ellagic acid is a precursor polyphenol found in pomegranates, berries, and walnuts. UA is the downstream metabolite produced when gut bacteria convert ellagic acid through 6+ steps. They are distinct compounds with different properties.

Q2.

Can I take ellagic acid instead of Urolithin A?

Only ~40% of people efficiently convert ellagic acid to UA. Ellagic acid has <1% oral bioavailability. Direct UA supplementation provides consistent plasma levels regardless of gut microbiome. For reliable UA levels, direct supplementation is superior.

Q3.

Does ellagic acid activate mitophagy?

No. Ellagic acid functions primarily as an in vitro antioxidant and free radical scavenger. UA's primary studied mechanism is PINK1/Parkin mitophagy activation. They have different primary mechanisms.

Q4.

What is ellagic acid's bioavailability?

Extremely low — <1% typically absorbed intact into systemic circulation. Its protein-binding properties in the gut form insoluble complexes that reduce absorption. This limits both therapeutic potential and systemic effects.

Q5.

Does ellagic acid have its own health benefits?

Yes. Ellagic acid has studied antioxidant properties — it scavenges free radicals and has been investigated for DNA protection in preclinical models. It inhibited cancer cell proliferation in vitro, but no human clinical trial has confirmed cancer prevention.

Q6.

What foods contain ellagic acid?

Raspberries (highest free ellagic acid, ~1500 μg/g dry weight), strawberries, pomegranates, walnuts, blackberries, pecans, and cranberries. These foods provide ellagic acid that gut bacteria can convert to UA.

Q7.

How is ellagic acid converted to Urolithin A?

Through 6+ sequential steps by gut bacteria: Urolithin M5 → M6 → M7 → Urolithin C → Isourolithin A → Urolithin A. Each step requires specific bacterial species (Gordonibacter and related). The process is highly variable between individuals.

Q8.

Is ellagic acid FDA approved for anything?

No. Ellagic acid is not FDA-approved to diagnose, treat, cure, or prevent any disease. The FDA has issued warning letters to companies making cancer prevention claims for ellagic acid supplements (unapproved drug claims).

Q9.

Can ellagic acid prevent cancer?

Ellagic acid inhibited cancer cell proliferation in multiple in vitro models, but no human clinical trial has confirmed cancer prevention efficacy. The FDA has issued warning letters for unapproved cancer prevention claims on ellagic acid supplements.

Q10.

Which is better absorbed — ellagic acid or Urolithin A?

Urolithin A. Direct UA supplementation achieves measurable plasma levels within 2–4 hours. Ellagic acid has <1% oral bioavailability — most is not absorbed intact. UA is far more bioavailable.

Q11.

Is ellagic acid an antioxidant?

Yes. Ellagic acid functions primarily as an in vitro antioxidant and free radical scavenger. UA's primary mechanism is mitophagy activation, not direct antioxidant activity. Different primary mechanisms.

Q12.

Can I take ellagic acid and Urolithin A together?

Combining them has not been studied. Ellagic acid provides antioxidant benefits independent of UA conversion. Taking both may offer complementary benefits. Consult a healthcare provider before combining.

Q13.

Does cooking destroy ellagic acid?

Ellagic acid is relatively heat-stable. Content varies by variety, ripeness, processing, and storage. Cooking does not significantly destroy ellagic acid, though it may alter the food matrix.

Q14.

Why is ellagic acid's bioavailability so low?

Ellagic acid's protein-binding properties in the gut form insoluble complexes that reduce absorption. Additionally, much is metabolized by gut bacteria before systemic absorption can occur. This results in <1% bioavailability.

Q15.

Which has more human clinical research?

UA has 8–10 published human trials specifically for UA supplementation. Ellagic acid has been studied in dietary/food context and preclinical models, but fewer direct human supplementation trials. Neither is FDA-approved for any condition.

Key Research Facts

1

Oral ellagic acid bioavailability is extremely low, with <1% typically absorbed intact into systemic circulation.

Strong Evidence

Lei et al., J Agric Food Chem — doi:10.1021/jf020136b

2

Ellagic acid is converted to Urolithin A through 6+ sequential steps by gut bacteria, requiring Gordonibacter and related species.

Strong Evidence

Tomás-Barberán et al., Mol Nutr Food Res — doi:10.1002/mnfr.201600440

3

Only approximately 40% of people efficiently produce Urolithin A from ellagic acid and ellagitannins due to gut microbiome variation.

Strong Evidence

Espín et al., Evid Based Complement Alternat Med — doi:10.1155/2013/270418

4

Ellagic acid inhibited cancer cell proliferation in multiple in vitro models, but no human clinical trial has confirmed cancer prevention efficacy.

Strong Evidence

Seeram et al., J Agric Food Chem — doi:10.1021/jf0428468

5

Direct Urolithin A supplementation achieves plasma levels within 2–4 hours, while ellagic acid from food produces highly variable and often undetectable UA levels.

Strong Evidence

Andreux et al., Nature Metabolism — doi:10.1038/s42255-019-0073-4

6

The FDA has issued warning letters to companies making cancer prevention claims for ellagic acid supplements, as these are unapproved drug claims.

Strong Evidence

FDA compliance actions — FDA Warning Letters database

7

Ellagic acid functions primarily as an in vitro antioxidant and free radical scavenger, while UA's primary studied mechanism is PINK1/Parkin mitophagy activation.

Strong Evidence

Daniel et al., 2006; Ryu et al., 2016 — Multiple DOIs

8

Raspberries contain the highest free ellagic acid among common fruits (approximately 1500 μg/g dry weight), followed by strawberries and pomegranates.

Moderate Evidence

Daniel et al., Crit Rev Food Sci Nutr — doi:10.1080/10408690490956517

9

No head-to-head clinical trial has compared ellagic acid supplementation with direct Urolithin A supplementation for any outcome.

Strong Evidence

ClinicalTrials.gov search — Accessed March 2026

10

Ellagic acid's protein-binding properties in the gut contribute to its poor absorption, as it forms insoluble complexes that reduce bioavailability.

Moderate Evidence

Lei et al., J Agric Food Chem — doi:10.1021/jf020136b

Continue Your Research

Explore related topics and take the next step in your cellular health journey.

Related Comparisons

Explore more head-to-head supplement comparisons backed by clinical evidence.

Citations & External Resources

Review

PubMed — Ellagic Acid research

Review

PubMed — Urolithin A research

Review

Tomás-Barberán et al. 2017 — Urolithin Metabotypes

Review

Nature Medicine — Ryu et al. 2016 (UA Landmark Study)

Review

Daniel et al. 2006 — Ellagic Acid Review

Clinical Registry

ClinicalTrials.gov — Search: Ellagic Acid

Regulatory

FDA — Dietary Supplement Compliance

Related Reading

References (3)

Written by

ReCellence™ Editorial Team

Health Content Specialists

Medically reviewed by

Medical Review Board

MD, PhD

Last updated: March 8, 2026

Last medical review: March 8, 2026